Integrated solutions to position your product for global success
Delivering commercially relevant and scientifically rigorous evidence to elevate your product’s value proposition and optimise reimbursement potential.
Delivering strategic market access expertise, to define, capture and communicate the value of medical therapies for optimal commercial results and greater patient access.
Our integrated market access, pricing, communications and health economics experts provide strategic guidance and tactical solutions to demonstrate the value of your product and support brand success around the globe. We help pharma, device and biotechnology companies at every stage of development, from endpoint selection and PRO development, through clinical trials, to post-approval and scientific publication.
Incorporating the patient's voice into drug and device development
Delivering research-driven payer, provider and patient insights
An award-winning, in-house design agency to support brand success
PubsHub medical communications software designed with your team in mind
Expertise and technology to identify, generate and synthesize real world data
Social media and digital technology are providing new opportunities for pharma marketers to make a fundamental difference.
In the US, ICER has emerged as a leading voice in evaluating the clinical and economic value of healthcare technologies. Read our third annual payer survey.
We look at how the pandemic could impact existing product pipelines and existing HEOR evidence planning and timetables.
With the increase in patient centricity, we surveyed US payers from MCOs, IDNs and PBMs to get their take on the value and use of patient reported outcome data.